Dynamic magnetic characterization and magnetic particle imaging enhancement of magnetic-gold core-shell nanoparticles.


Journal

Nanoscale
ISSN: 2040-3372
Titre abrégé: Nanoscale
Pays: England
ID NLM: 101525249

Informations de publication

Date de publication:
28 Mar 2019
Historique:
pubmed: 21 3 2019
medline: 28 5 2019
entrez: 21 3 2019
Statut: ppublish

Résumé

Multifunctional nanoparticles with a magnetic core and gold shell structures are emerging multi-modal imaging probes for disease diagnosis, image-guided therapy, and theranostic applications. Owing to their multi-functional magnetic and plasmonic properties, these nanoparticles can be used as contrast agents in multiple complementary imaging modalities. Magnetic particle imaging (MPI) is a new pre-clinical imaging system that enables real-time imaging with high sensitivity and spatial resolution by detecting the dynamic responses of nanoparticle tracers. In this study, we evaluated the dynamic magnetic properties and MPI imaging performances of core-shell nanoparticles with a magnetic core coated with a gold shell. A change in AC hysteresis loops was detected before and after the formation of the gold shell on magnetic core nanoparticles, suggesting the influence of the core-shell interfacial effect on their dynamic magnetic properties. This alteration in the dynamic responses resulted in an enhancement of the MPI imaging capacity of magnetic nanoparticles. The gold shell coating also enabled a simple and effective functionalization of the nanoparticles with a brain glioma targeting ligand. The enhanced MPI imaging capacity and effective functionality suggest the potential application of the magnetic-gold core-shell nanoparticles for MPI disease diagnostics.

Identifiants

pubmed: 30892348
doi: 10.1039/c9nr00242a
pmc: PMC6464385
mid: NIHMS1019519
doi:

Substances chimiques

Chlorides 0
Contrast Media 0
Ferric Compounds 0
Magnetite Nanoparticles 0
Sulfhydryl Compounds 0
Gold 7440-57-5
ferric chloride U38V3ZVV3V

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6489-6496

Subventions

Organisme : NCI NIH HHS
ID : T32 CA009695
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA042706
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI073961
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA037838
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA040537
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA034547
Pays : United States

Commentaires et corrections

Type : ErratumIn

Références

Chem Commun (Camb). 2016 Nov 8;52(91):13337-13340
pubmed: 27709207
Chem Soc Rev. 2012 Apr 7;41(7):2656-72
pubmed: 22189429
IEEE Trans Med Imaging. 2015 May;34(5):1077-84
pubmed: 25438306
Materials (Basel). 2018 Oct 28;11(11):
pubmed: 30373290
Chem Rev. 2015 Oct 14;115(19):10637-89
pubmed: 26250431
Nano Lett. 2017 Mar 8;17(3):1648-1654
pubmed: 28206771
Theranostics. 2016 Jan 01;6(3):291-301
pubmed: 26909106
Sci Rep. 2015 Nov 13;5:16139
pubmed: 26563520
Beilstein J Nanotechnol. 2017 Feb 6;8:372-380
pubmed: 28326226
IEEE Trans Magn. 2015 Feb;51(2):
pubmed: 26023242
Nature. 2005 Jun 30;435(7046):1214-7
pubmed: 15988521
Med Phys. 2013 Jul;40(7):071904
pubmed: 23822441
Phys Rev B Condens Matter. 1989 Jan 1;39(1):865-868
pubmed: 9947253
Sci Rep. 2015 Sep 11;5:14055
pubmed: 26358296
Int J Mol Sci. 2013 Oct 25;14(11):21266-305
pubmed: 24232575
Nanoscale. 2017 Dec 21;10(1):184-194
pubmed: 29210401
J Magn Magn Mater. 2009;321(10):1548-1551
pubmed: 19606261
Bioconjug Chem. 2011 Oct 19;22(10):1879-903
pubmed: 21830812
ACS Appl Mater Interfaces. 2017 Nov 15;9(45):39249-39258
pubmed: 29039909
Mol Pharm. 2010 Dec 6;7(6):1899-912
pubmed: 20822168
Phys Rev Lett. 2009 Aug 7;103(6):067202
pubmed: 19792607
Nanoscale. 2015 Feb 7;7(5):1782-90
pubmed: 25519743
Drug Deliv Transl Res. 2018 Oct;8(5):1545-1563
pubmed: 29916012
Biomed Tech (Berl). 2013 Dec;58(6):493-507
pubmed: 23787461
Chem Commun (Camb). 2016 Jun 18;52(48):7528-40
pubmed: 27182032
IEEE Trans Med Imaging. 2012 Dec;31(12):2335-42
pubmed: 22968211
Med Phys. 2014 Jan;41(1):012301
pubmed: 24387522
Int J Nanomedicine. 2015 Apr 22;10:3097-114
pubmed: 25960650
Adv Mater. 2012 Jul 24;24(28):3870-7
pubmed: 22988557
Chem Rev. 2012 Apr 11;112(4):2373-433
pubmed: 22204603
Radiol Phys Technol. 2013 Jul;6(2):399-414
pubmed: 23589334
Nanoscale. 2017 Jan 5;9(2):764-773
pubmed: 27976764
Theranostics. 2014 Mar 26;4(6):660-77
pubmed: 24723986
PLoS One. 2012;7(5):e37376
pubmed: 22615995
RSC Adv. 2017 Mar 19;7(28):17137-17153
pubmed: 28603606
Phys Rev B Condens Matter Mater Phys. 2015;92(9):
pubmed: 26504371
Appl Phys Lett. 2014 Mar 10;104(10):102403
pubmed: 24753618

Auteurs

Asahi Tomitaka (A)

Department of Immunology and Nano-Medicine, Institute of NeuroImmune Pharmacology, Centre for Personalized Nanomedicine, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida 33199, USA. nairm@fiu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH